Skip to main content
. 2019 Dec 10;6:291. doi: 10.3389/fmed.2019.00291

Table 2.

The characteristics of patients with pSS and non-SS-MGD according medical history.

Variables pSS (≤3y) Non-SS-MGD (≤3y) pSS (>3y) Non-SS-MGD (>3y)
Female 26 27 23 25
Age (years) 47.26 ± 11.18 46.73 ± 11.39 51.55 ± 8.86 49.91 ± 12.35
Medical history (months) 17.91 ± 14.21 16.97 ± 15.36 82.96 ± 30.68 80.66 ± 31.72
OSDI 25.56 ± 10.01 19.46 ± 8.44b 31.73 ± 9.85 20.49 ± 7.71b
Schirmer I test (mm) OD 4.78 ± 0.79 7.21 ± 0.91b 3.11 ± 0.75 7.91 ± 0.93b
OS 4.80 ± 0.81 7.28 ± 0.89b 3.18 ± 0.69 7.98 ± 0.91b
BUT (s) OD 4.21 ± 2.17 6.97 ± 3.79b 2.31 ± 1.85 6.38 ± 3.81b
OS 4.19 ± 2.09 7.01 ± 3.79b 2.23 ± 1.72 6.09 ± 3.54b
CFS (score) OD 7.12 ± 5.33 4.26 ± 2.15b 9.31 ± 5.11 5.12 ± 2.98b
OS 7.09 ± 5.26 4.31 ± 3.32b 9.27 ± 5.37 5.11 ± 2.95b
TMH (mm) OD 0.09 ± 0.10 0.13 ± 0.16a 0.07 ± 0.12 0.13 ± 0.19a
OS 0.09 ± 0.11 0.12 ± 0.18a 0.07 ± 0.11 0.12 ± 0.16a

Symptoms and DED related examinations in the patients with pSS compared to non-SS-related MGD. Values equal the mean ± SE. DED, dry eye disease; MGD, meibomian gland dysfunction; pSS, primary Sjögren syndrome; OSDI, Ocular Surface Disease Index.

a, b

Significantly (ap < 0.05, bp ≤ 0.01) greater than in the controls.